M&A Deal Summary |
|
|---|---|
| Date | 2022-05-19 |
| Target | Syrinx Bioanalytics |
| Sector | Life Science |
| Buyer(s) | Symeres |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Symeres is a mid-sized European Contract Research Organization for drug discovery and development needs. With over 500 employees at six locations (Groningen, Nijmegen, & Weert in the Netherlands, Prague in the Czech Republic, Oulu in Finland, and Södertälje in Sweden), as well as a business development office in the US, the company offers best-in-class solutions for drug discovery and drug development for small molecules and beyond. Their services span from preclinical hit finding all the way to the delivery of early clinical phase drug substance API. Symeres blends a deep scientific knowledge base with creativity and problem-solving skills to deliver the quality results that clients need.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 2 of 2 |
| Type (Add-on Acquisition) | 2 of 2 |
| Country (Finland) | 1 of 1 |
| Year (2022) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-26 |
Organix
Woburn, Massachusetts, United States Organix is specialized organic chemistry services provider with a focus on lipids. Organix was founded in 1986 and is based in Woburn, Massachusetts. |
Buy | - |
